Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

Published:2012-07 Issue:10 Volume:48 Page:1452-1465
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Cheng Ann-Lii,Guan Zhongzhen,Chen Zhendong,Tsao Chao-Jung,Qin Shukui,Kim Jun Suk,Yang Tsai-Sheng,Tak Won Young,Pan Hongming,Yu Shiying,Xu Jianming,Fang Fang,Zou Jessie,Lentini Giuseppe,Voliotis Dimitris,Kang Yoon-Koo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Epidemiology of liver cancer: an overview;Srivatanakul;Asian Pac J Cancer Prev,2004

3. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma;Kew;Pathol Biol (Paris),2010

4. BAY 43–9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/MERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res,2004

5. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF amd PDGF receptor tyrosine kinase signaling;Wilhelm;Mol Cancer Ther,2008

Cited by 234 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma;Journal of Hepatology;2024-07

2. A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1;Journal of Hepatocellular Carcinoma;2024-05

3. Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma;Cellular Signalling;2024-05

4. Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review;Expert Review of Anticancer Therapy;2024-04-24

5. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-01